(Q41614070)

5 October 2017

Single- and multiple-dose pharmacokinetics of ziprasidone under non-fasting conditions in healthy male volunteers (English)

1 reference

5 October 2017

1 reference

J J Miceli

1

1 reference

5 October 2017

K D Wilner

2

1 reference

5 October 2017

R A Hansen

3

1 reference

5 October 2017

A C Johnson

4

1 reference

5 October 2017

G Apseloff

5

1 reference

5 October 2017

N Gerber

6

1 reference

5 October 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

British Journal of Clinical Pharmacology

5 October 2017

1 reference

5 October 2017

49 Suppl 1

1 reference

5 October 2017

5S-13S

1 reference

Risperidone: efficacy and safety

5 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015059

A comparison of the neuro-endocrinological and temperature effects of DU 29894, flesinoxan, sulpiride and haloperidol in normal volunteers

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015059

Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015059

Risperidone: review and assessment of its role in the treatment of schizophrenia

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015059

Prospects for pharmacotherapy of schizophrenia

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015059

Pharmacological profile of risperidone

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015059

Prolactin-Lowering and -Releasing Drugs Mechanisms of Action and Therapeutic Applications

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015059

A rating scale for extrapyramidal side effects

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015059

Hyperprolactinemia and sexual function in men.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015059

A rating scale for drug-induced akathisia

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015059

The Mechanism of Action of Novel Antipsychotic Drugs

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015059

Treatment of the neuroleptic-nonresponsive schizophrenic patient

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015059

Decreased bone mineral density in medicated psychiatric patients.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015059

Compliance with antipsychotic drug treatment: influence of side effects.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015059

Hyperprolactinemia and sexual disorders in men.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2015059

Clozapine does not elevate serum prolactin levels in healthy men

19 August 2018

1 reference

12 December 2020

Development and validation of a high-sensitivity assay for an antipsychotic agent, CP-88,059, with solid-phase extraction and narrow-bore high-performance liquid chromatography

1 reference

12 December 2020

1983 metropolitan height and weight tables

1 reference

12 December 2020

Bone density and reproductive hormones in patients with neuroleptic-induced hyperprolactinemia

1 reference

12 December 2020

Therapeutic effect and safety of increasing doses of risperidone (R 64766) in psychotic patients

1 reference

12 December 2020

Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study

1 reference

12 December 2020

Risperidone in the treatment of chronic schizophrenic patients: an international double-blind parallel-group study versus haloperidol. The International Risperidone Research Group

1 reference

12 December 2020

10.1046/J.1365-2125.2000.00147.X

Identifiers

DOI

1 reference

5 October 2017

1 reference

5 October 2017

PubMed publication ID

10771448

1 reference